Catalyst -Manual Compression Assist Device
Studies Have Demonstrated a Reduction in Time to Hemostasis and Ambulation When Compared to Manual Compression. CATALYST is designed to provide temporary hemostasis and enhance coagulation for patients requiring manual compression – helping to reduce mean hold time by over 50% and reduce time to ambulation by more than 20% as compared to manual compression.
The CATALYST II and CATALYST III manual compression assist devices employ Cardiva’s proven proprietary collapsible disc technology and two different hemostatic coatings based on the presence of heparin. CATALYST II is coated with kaolin and chitosan used to promote coagulation by activating the clotting cascade and causing platelet aggregation. CATALYST III is coated with an additional drug, protamine sulfate, acting locally to neutralize heparin and further aid the body’s natural healing process.
Studies Have Shown Less Hold Time and Faster Ambulation
Cardiva`s CATALYST® Manual Compression Assist Device and its predecessors have been utilized in over 400,000 procedures since the product launched in 2005. CATALYST is designed to provide greater efficiency for clinical staff and faster recovery time for patients.
- CATALYST II coated with kaolin and chitosan
- CATALYST III adds protamine sulfate to neutralize heparin
- Leaves nothing behind to allow for immediate reaccess
- In selected studies, CATALYST have shown
- Greater than 50% reduction in mean hold time
- More than 20% reduction in ambulation time
- Enhances tissue apposition, natural elastic recoil and coagulation
- Helps maintain vessel integrity
- Supports the body’s natural healing process
- Allows immediate reaccess with no part of the device left behind
- More efficient for clinical staff and more comfortable for patients